Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by McWherter Charles. Director active across 2 companies, notably CymaBay Therapeutics, Inc.. In total, 13 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €108k. History available since 18 May 2023. The latest transaction was disclosed on 21 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.